retatrutide phase 2 nejm weight loss 48 weeks triple agonist First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, GLP-1 & Glucagon hormone receptor drug leads to nearly 29% in first pivotal test! Eli Lilly announced positive topline results from the Retatrutide vs Semaglutide: Triple vs

Key Takeaways GLP-1 medications reduce food noise by dampening dopamine-driven cravings, helping separate true hunger from impulse-driven eating, and creating more control around food choices

These effects were considered clinically relevant and may guide the targeted use of GLP-1RAs in managing conditions associated with inflammation and oxidative stress

TMAO: trimethylamine- N -oxide

When travel or holidays disrupt routines, return to defaults within one or two days rather than waiting for a perfect Monday. Consistency beats intensity for endogenous hormone-friendly habits

The caption of the announcement post read, Introducing Lemme GLP-1 Daily